Decades of experience and a drive to innovate, guide our team’s mission to improve patient outcomes - today.
Pioneering entrepreneur in women’s health. André is the founder and former CEO of HRA Pharma, where he developed and marketed the first ‘morning after pill’. Since HRA, André has continued to be a leader in the world of reproductive health, working as an activist, adviser and investor. André co-founded Nulyn Science with Arnold Newman, COO, to continue tackling today’s public health emergencies.
Inventor and serial entrepreneur. At Johns Hopkins Applied Physics Lab, Arnold worked on the first implantable defibrillator and other medical devices, satellites, and deep space probes. There he invented a biosensor technology that formed the basis of his first company. He has gone on to found or co-found companies involved in the design and production of early drone models, the development of the first anti-fibrosis drug, and even the chemical synthesis of diamonds. Arnold brings his wealth of experience to Nulyn Science as Co-founder and COO.
Expert in early stage start-up operations. Antoine has worked with several startup founders through the early challenges of defining and implementing a product roadmap, while growing a strong team. He has joined Nulyn Science as the company’s first Project Manager and oversees the progress of the company’s products and internal priorities.
